- Home
- SCOR vs CGTX Comparison
SCOR vs CGTX Comparison
Compare SCOR & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCOR | CGTX |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 158.8M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SCOR | CGTX |
|---|---|---|
| Price | $7.04 | $1.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 7.7K | ★ 953.6K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $358,940,000.00 | N/A |
| Revenue This Year | $2.01 | N/A |
| Revenue Next Year | $1.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $4.39 | $0.22 |
| 52 Week High | $10.18 | $3.83 |
Technical Indicators
Market Signals| Indicator | SCOR | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 43.28 |
| Support Level | $6.51 | $1.69 |
| Resistance Level | $7.15 | $1.76 |
| Average True Range (ATR) | 0.39 | 0.11 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 87.50 | 4.69 |
Price Performance
Historical ComparisonAbout SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.